Home

GRI Bio, Inc. - Common Stock (GRI)

1.8100
-0.2400 (-11.71%)
NASDAQ · Last Trade: Sep 14th, 6:53 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.050
Open2.060
Bid1.800
Ask1.830
Day's Range1.760 - 2.060
52 Week Range1.100 - 30.43
Volume1,010,923
Market Cap12.33M
PE Ratio (TTM)-0.0310
EPS (TTM)-58.4
Dividend & YieldN/A (N/A)
1 Month Average Volume3,018,034

Chart

About GRI Bio, Inc. - Common Stock (GRI)

Gri Bio Inc is a biotechnology company focused on developing innovative therapies to enhance the immune response and improve the treatment of various diseases. The company leverages its proprietary technology platform to identify and create novel biopharmaceutical products aimed at addressing unmet medical needs in areas such as immunology and oncology. By harnessing the power of the immune system, Gri Bio strives to deliver breakthrough treatments that can significantly impact patient outcomes and contribute to advancements in modern medicine. Read More

News & Press Releases

12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 12, 2025
Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 12, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · September 11, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · September 11, 2025
Crude Oil Falls 1%; Meta Earnings Top Viewsbenzinga.com
Via Benzinga · July 31, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · July 31, 2025
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earningsbenzinga.com
Via Benzinga · July 31, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · July 22, 2025
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
- Video webcasts from participating companies now available here
Via ACCESS Newswire · July 22, 2025
Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?benzinga.com
GRI Bio reported interim Phase 2a results for GRI-0621 in IPF, showing safety and no significant cholesterol changes.
Via Benzinga · April 1, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · March 17, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 15, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · November 1, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 23, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 22, 2024
Dow Falls Over 150 Points; General Motors Tops Q3 Viewsbenzinga.com
Via Benzinga · October 22, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 22, 2024
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 22, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · October 21, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 21, 2024
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 21, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 18, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 14, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 8, 2024
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 8, 2024